16-89561263-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_000977.4(RPL13):c.141C>T(p.Ala47Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.19 in 1,553,686 control chromosomes in the GnomAD database, including 28,959 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 2289 hom., cov: 34)
Exomes 𝑓: 0.19 ( 26670 hom. )
Consequence
RPL13
NM_000977.4 synonymous
NM_000977.4 synonymous
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 0.0930
Genes affected
RPL13 (HGNC:10303): (ribosomal protein L13) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L13E family of ribosomal proteins. It is located in the cytoplasm. This gene is expressed at significantly higher levels in benign breast lesions than in breast carcinomas. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.21).
BP6
Variant 16-89561263-C-T is Benign according to our data. Variant chr16-89561263-C-T is described in ClinVar as [Benign]. Clinvar id is 1327971.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.093 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.193 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPL13 | NM_000977.4 | c.141C>T | p.Ala47Ala | synonymous_variant | Exon 3 of 6 | ENST00000311528.10 | NP_000968.2 | |
RPL13 | NM_033251.2 | c.141C>T | p.Ala47Ala | synonymous_variant | Exon 2 of 5 | NP_150254.1 | ||
RPL13 | NM_001243131.1 | c.141C>T | p.Ala47Ala | synonymous_variant | Exon 3 of 7 | NP_001230060.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.167 AC: 25426AN: 152106Hom.: 2284 Cov.: 34
GnomAD3 genomes
AF:
AC:
25426
AN:
152106
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.164 AC: 25264AN: 153978Hom.: 2279 AF XY: 0.167 AC XY: 14243AN XY: 85444
GnomAD3 exomes
AF:
AC:
25264
AN:
153978
Hom.:
AF XY:
AC XY:
14243
AN XY:
85444
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.192 AC: 269238AN: 1401460Hom.: 26670 Cov.: 34 AF XY: 0.191 AC XY: 132561AN XY: 693542
GnomAD4 exome
AF:
AC:
269238
AN:
1401460
Hom.:
Cov.:
34
AF XY:
AC XY:
132561
AN XY:
693542
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.167 AC: 25450AN: 152226Hom.: 2289 Cov.: 34 AF XY: 0.162 AC XY: 12063AN XY: 74428
GnomAD4 genome
AF:
AC:
25450
AN:
152226
Hom.:
Cov.:
34
AF XY:
AC XY:
12063
AN XY:
74428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
408
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Spondyloepimetaphyseal dysplasia, Isidor-Toutain type Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at